Kwon I - Search Results

1

AlbuCatcher for Long-Acting Therapeutics.

Rho JH, Lee JH, Kwon I. Rho JH, et al. Among authors: kwon i. ACS Omega. 2024 May 13;9(21):22990-23000. doi: 10.1021/acsomega.4c02303. eCollection 2024 May 28. ACS Omega. 2024. PMID: 38826564 Free PMC article.

2

Computation-Aided Design of Albumin Affibody-Inserted Antibody Fragment for the Prolonged Serum Half-Life.

Kwon NH, Lee JH, Kwon I. Kwon NH, et al. Among authors: kwon i. Pharmaceutics. 2022 Aug 24;14(9):1769. doi: 10.3390/pharmaceutics14091769. Pharmaceutics. 2022. PMID: 36145517 Free PMC article.

3

In vivo study of newly developed albumin-conjugated urate oxidase for gout treatment.

Cho J, Yang B, Lee JH, Kim H, Kim H, Go EB, Bak DH, Park SJ, Kwon I, Choi JI, Lee K. Cho J, et al. Among authors: kwon i. Arthritis Res Ther. 2023 Dec 18;25(1):247. doi: 10.1186/s13075-023-03231-3. Arthritis Res Ther. 2023. PMID: 38111075 Free PMC article.

4

Enhanced therapeutic potential of antibody fragment via IEDDA-mediated site-specific albumin conjugation.

Go EB, Lee JH, Cho JH, Kwon NH, Choi JI, Kwon I. Go EB, et al. Among authors: kwon i, kwon nh. J Biol Eng. 2024 Apr 4;18(1):23. doi: 10.1186/s13036-024-00418-3. J Biol Eng. 2024. PMID: 38576037 Free PMC article.

5

Site-Specific Conjugation of Bottlebrush Polymers to Therapeutic Protein via Bioorthogonal Chemistry.

Saha B, Lee JH, Kwon I, Chung H. Saha B, et al. Among authors: kwon i. Biomacromolecules. 2024 May 13;25(5):3200-3211. doi: 10.1021/acs.biomac.4c00359. Epub 2024 Apr 9. Biomacromolecules. 2024. PMID: 38591457

6

Recombinant Peptide Production Platform Coupled with Site-Specific Albumin Conjugation Enables a Convenient Production of Long-Acting Therapeutic Peptide.

Bak M, Park J, Min K, Cho J, Seong J, Hahn YS, Tae G, Kwon I. Bak M, et al. Among authors: kwon i. Pharmaceutics. 2020 Apr 16;12(4):364. doi: 10.3390/pharmaceutics12040364. Pharmaceutics. 2020. PMID: 32316169 Free PMC article.

7

Thermostable and Long-Circulating Albumin-Conjugated Arthrobacter globiformis Urate Oxidase.

Yang B, Kwon I. Yang B, et al. Among authors: kwon i. Pharmaceutics. 2021 Aug 19;13(8):1298. doi: 10.3390/pharmaceutics13081298. Pharmaceutics. 2021. PMID: 34452259 Free PMC article.

8

Multivalent Albumin-Neonatal Fc Receptor Interactions Mediate a Prominent Extension of the Serum Half-Life of a Therapeutic Protein.

Yang B, Kwon I. Yang B, et al. Among authors: kwon i. Mol Pharm. 2021 Jun 7;18(6):2397-2405. doi: 10.1021/acs.molpharmaceut.1c00231. Epub 2021 May 13. Mol Pharm. 2021. PMID: 33983743

9

Chemical Modification of Cysteine with 3-Arylpropriolonitrile Improves the In Vivo Stability of Albumin-Conjugated Urate Oxidase Therapeutic Protein.

Yang B, Kwon I. Yang B, et al. Among authors: kwon i. Biomedicines. 2021 Sep 27;9(10):1334. doi: 10.3390/biomedicines9101334. Biomedicines. 2021. PMID: 34680451 Free PMC article.

10

The Minimal Effect of Linker Length for Fatty Acid Conjugation to a Small Protein on the Serum Half-Life Extension.

Cho J, Park J, Tae G, Jin MS, Kwon I. Cho J, et al. Among authors: kwon i. Biomedicines. 2020 Apr 26;8(5):96. doi: 10.3390/biomedicines8050096. Biomedicines. 2020. PMID: 32357510 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,121 results

Search Page

Filters